Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Operating Leases (2021 - 2022)

Usana Health Sciences (USNA) has disclosed Operating Leases for 1 consecutive years, with $7.1 million as the latest value for Q1 2022.

  • On a quarterly basis, Operating Leases changed N/A to $7.1 million in Q1 2022 year-over-year; TTM through Jan 2022 was $7.1 million, a N/A change, with the full-year FY2022 number at $7.1 million, changed N/A from a year prior.
  • Operating Leases was $7.1 million for Q1 2022 at Usana Health Sciences.
  • In the past five years, Operating Leases ranged from a high of $7.1 million in Q1 2022 to a low of $7.1 million in Q1 2022.